New Jersey Assembly Bill A2403

New Jersey 2024-2025 Regular Session

• Introduced: 1/9/24
• Refer: 1/9/24

Caption

Requires emergency medical services provider to provide certain information regarding person who experienced drug overdose to DLPS.

Impact

If enacted, A2403 will amend current statutory provisions to formalize the communication system between EMS providers and the Department of Law and Public Safety. By mandating that EMS providers supply information after administering an opioid antidote or other emergency treatments, the bill seeks to address the critical need for timely engagement with individuals suffering from substance use disorders. This legislative change is expected to link overdose patients with essential support services and recovery resources as part of a broader approach to combat the opioid crisis in New Jersey.

Summary

Assembly Bill A2403 aims to enhance public health response to drug overdoses by requiring emergency medical services (EMS) providers to report specific information about individuals who experience drug overdoses to the Department of Law and Public Safety. The intent behind this measure is to provide affected individuals with information regarding harm reduction strategies and available recovery resources following an overdose, ultimately aiming to facilitate better health outcomes for these individuals and mitigate the risks associated with drug misuse.

Contention

Debate surrounding A2403 may center on concerns regarding patient privacy and the burden of reporting requirements on EMS providers. Some stakeholders may worry that mandated reporting could deter individuals from seeking help in future overdose situations due to fear of criminalization or stigma. Furthermore, while proponents advocate for the potential life-saving benefits of the bill, critics might voice apprehension regarding the practical implications of how information will be handled and the effectiveness of follow-up interventions proposed under the bill.